Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Clinical trial NCT01086423 · COMPLETED

Trial details

NCT number: NCT01086423
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Poliomyelitis Acellular Pertussis Diphtheria Haemophilus Influenzae Type b

Start date: 2010-03-01
Primary completion: 2010-11-19
Enrollment: 985

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.